Allurion Technologies Inc. (NYSE:ALUR – Get Free Report) was the target of a significant increase in short interest in the month of June. As of June 30th, there was short interest totalling 1,020,000 shares, an increase of 93.9% from the June 15th total of 526,100 shares. Based on an average trading volume of 1,250,000 shares, the days-to-cover ratio is currently 0.8 days. Approximately 2.5% of the shares of the stock are sold short.
Wall Street Analysts Forecast Growth
Separately, Chardan Capital reissued a “buy” rating and set a $5.00 price target on shares of Allurion Technologies in a report on Wednesday, May 15th.
Get Our Latest Stock Report on ALUR
Allurion Technologies Price Performance
Allurion Technologies (NYSE:ALUR – Get Free Report) last issued its quarterly earnings data on Tuesday, May 14th. The company reported $0.11 earnings per share for the quarter. The firm had revenue of $9.39 million for the quarter. On average, research analysts predict that Allurion Technologies will post -0.65 earnings per share for the current fiscal year.
About Allurion Technologies
Allurion Technologies Inc focuses on ending obesity with a weight loss platform to treat people who are overweight. Its platform, the Allurion Program, features swallowable and procedure-less intragastric balloon for weight loss (the Allurion Balloon), as well as offers access to AI-powered remote patient monitoring tools, a proprietary behavior change program, secure messaging, and video telehealth that are delivered by the Allurion Virtual Care Suite.
Featured Stories
- Five stocks we like better than Allurion Technologies
- 3 Must-Buy Warren Buffett Stocks for Volatile Times
- Top 3 Beverage Stocks: Summer Earnings Reveal Key Trends
- Why Invest in High-Yield Dividend Stocks?
- This Financial Stock’s Earnings Signal a Buying Opportunity
- How Investors Can Identify and Successfully Trade Gap-Down Stocks
- Social Platform Stock Hits New Highs: Is More Growth Ahead?
Receive News & Ratings for Allurion Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Allurion Technologies and related companies with MarketBeat.com's FREE daily email newsletter.